CS, P., CM, P., M, M., LS, G., D, I., AE, C., . . . L, I. (2020). Occurrence and recurrence of hepatocellular carcinoma in patients with HCV genotype 1b related cirrhosis treated with Ledipasvir + Sofosbuvir ± Ribavirin. Journal of gastrointestinal and liver diseases : JGLD, 29(4), 690. https://doi.org/10.15403/jgld-3148
Chicago Style (17th ed.) CitationCS, Pop, et al. "Occurrence and Recurrence of Hepatocellular Carcinoma in Patients with HCV Genotype 1b Related Cirrhosis Treated with Ledipasvir + Sofosbuvir ± Ribavirin." Journal of Gastrointestinal and Liver Diseases : JGLD 29, no. 4 (2020): 690. https://doi.org/10.15403/jgld-3148.
MLA (9th ed.) CitationCS, Pop, et al. "Occurrence and Recurrence of Hepatocellular Carcinoma in Patients with HCV Genotype 1b Related Cirrhosis Treated with Ledipasvir + Sofosbuvir ± Ribavirin." Journal of Gastrointestinal and Liver Diseases : JGLD, vol. 29, no. 4, 2020, p. 690, https://doi.org/10.15403/jgld-3148.